Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease

Europace

Volumn 12, Issue 11, 2010, Pages 1581-1588

  Atary, Jael Z ^a   Borleffs, C Jan Willem ^a   Van Der Bom, Johanna G ^a   Trines, Serge A I P ^a   Bootsma, Marianne ^a   Zeppenfeld, Katja ^a   Van Erven, Lieselot ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Implantable cardioverter defibrillator; Primary prevention; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PRIMARY PREVENTION; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 78149248034     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq266     Document Type: Article

References (31)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
2. Epstein AE, Di Marco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117: e350-e408.
3. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
6. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
7. Morishima I, Sone T, Tsuboi H, Mukawa H, Uesugi M, Morikawa S et al. Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging. J Nucl Cardiol 2008;15:631-7.
8. Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996;27:1119-27.
9. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 2008;52:1179-99.
10. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.
11. Boineau JP, Cox JL. Slow ventricular activation in acute myocardial infarction. A source of re-entrant premature ventricular contractions. Circulation 1973;48:702-13.
12. Spear JF, Michelson EL, Moore EN. Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1983;1:1099-110.
13. Spear JF, Michelson EL, Moore EN. Reduced space constant in slowly conducting regions of chronically infarcted canine myocardium. Circ Res 1983;53:176-85.
14. Buxton AE. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction
15. Cohen RJ. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population. Card Electrophysiol Rev 2003;7:438-42.
16. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006;47:98-107.
17. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-90.
18. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96.
19. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001;103:2072-7.
20. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K et al. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004;15:993-8.
21. Ueno A, Kobayashi Y, Yodogawa K, Miyauchi Y, Yajima T, Nitta T et al. A prospective study on the risk-stratification for patients with non-sustained ventricular tachycardia using a novel algorithm. Circ J 2007;71:1107-14.
22. Zareba W, Piotrowicz K, McNitt S, Moss AJ. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Am J Cardiol 2005;95:1487-91.
23. Starobin JM, Zilberter YI, Rusnak EM, Starmer CF. Wavelet formation in excitable cardiac tissue: the role of wavefront-obstacle interactions in initiating highfrequency fibrillatory-like arrhythmias. Biophys J 1996;70:581-94.
24. Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol 1984;54:755-61.
25. Leier CV, Meacham JA, Schaal SF. Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter. Circulation 1978;57:213-6.
26. Yamashita T, Oikawa N, Inoue H, Murakawa Y, Nakajima T, Usui M et al. Slow abnormal conduction in the low right atrium: its anatomic basis and relevance to atrial reentry. Am Heart J 1994;127:353-9.
27. Dohrmann ML, Goldschlager NF. Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin 1985;3:527-37.
28. Furman S. Basic concepts. In Furman S, Hayee DL, Holmes DR (eds). A Practice of Cardiac Pacing, 3rd ed. New York, NY: Futura Publishing; 2009. p68-71. 1993 p.
29. Neal Kay G. Basic Concepts of Pacing. In Ellenbogen KA, Wood MA (eds)., Cardiac Pacing and ICDs. 4th ed. Massachusetts, USA: Blackwell Publishing; 2005. p47-121.
30. Neal Kay G. Basic Principles of Pacing. Cardiac Pacing and ICDs. 4th ed. Blackwell Publishing; 2005. p47-121.
31. Stokes KB, Bornzin G. The electrode-biointerface: stimulation. In Barold SS (ed.) Modern Cardiac Pacing. Mt Kisco, NY: Futura Publishing; 1985. p33-77.